Delivery Order SPE2DB22D9353-SPE2DB25FX2AW
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $29.3 thousand by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. The contract covers the delivery of EYLEA 2 mg/0.05 ml syringes to support federal healthcare requirements, with an ultimate completion date of August 18, 2025. This delivery order was issued without a set-aside designation and is...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,940.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, which has a completion date of July 18, 2024, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product used to treat certain medical conditions. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,850.16 on July 21, 2025, for the supply of EYLEA HD 8 mg/0.07 ml vials. This delivery order, with an ultimate completion date of August 11, 2025, was issued without a set-aside designation and will be performed at the awardee's Park Ridge location. The order is funded through the Defense Logistics Agency's Medical...
- The U.S. Defense Logistics Agency has awarded a firm fixed-price delivery order contract worth $12,919.30 to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The contract is for the delivery of EYLEA 2 MG/0.05 ML syringes, and has a completion date of February 28, 2024. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, that DMS Pharmaceutical Group holds with the Defense Logistics Agency. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,925.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a specialized pharmaceutical product, with a period of performance through April 8, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $54,016.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which runs through December 31, 2025. The delivery order is for the pharmaceutical product EYLEA 2 MG/0.05 ML VIAL 0.05ML, with a...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against the Defense Logistics Agency's pharmaceutical prime vendor contract for $33,760 to supply Eylea 2 mg/0.05 ml vials in Park Ridge, Illinois. The order was issued by Defense Logistics Agency Troop Support Medical on November 2, 2023 to fulfill requirements through November 27, 2023. DMS Pharmaceutical Group holds indefinite delivery contracts with DLA to provide pharmaceuticals and medical supplies with a...
- The U.S. Department of Defense's Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,761.76 contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a medication, with a period of performance through September 23, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $1,305.61 contract is for the delivery of EYLEA 2MG/0.05ML SY 1S pharmaceutical products with a completion date of February 13, 2024. This delivery order is issued under DMS Pharmaceutical Group's $4,999,999 indefinite delivery contract with DLA for a broad range of pharmaceutical items to support the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,906.30 firm fixed-price contract is for the supply of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a pharmaceutical product, with a period of performance through June 10, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2AWDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,943.78 by the Defense Logistics Agency on July 31, 2025. The contract calls for delivery of EYLEA HD 8 mg/0.07 ml vials, a pharmaceutical product used to treat eye conditions, with an ultimate completion date of August 21, 2025. The award was issued without a set-aside designation and specifies Park Ridge, Illinois as the place of performance. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which is valued at approximately $500 million and remains valid through November 2026. This indefinite delivery vehicle enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare facilities. DMS Pharmaceutical Group's positioning as a key federal pharmaceutical supplier reflects its established role in the Department of Defense supply chain, providing branded and generic prescription drugs, biologics, and medical consumables directly to military health facilities nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 7/31/25 |